Coronavirus Disease 2019 (COVID-19) Prevalences Among People Experiencing Homelessness and Homelessness Service Staff During Early Community Transmission in Atlanta, Georgia, April–May 2020
- 8 September 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 73 (9), e2978-e2984
- https://doi.org/10.1093/cid/ciaa1340
Abstract
Background: In response to reported coronavirus disease 2019 (COVID-19) outbreaks among people experiencing homelessness (PEH) in other US cities, we conducted multiple, proactive, facility-wide testing events for PEH living sheltered and unsheltered and homelessness service staff in Atlanta, Georgia. We describe the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) prevalence and associated symptoms, and review shelter infection prevention and control (IPC) policies. Methods: PEH and staff were tested for SARS-CoV-2 by reverse transcription polymerase chain reaction (RT-PCR) during 7 April–6 May 2020. A subset of PEH and staff was screened for symptoms. Shelter assessments were conducted concurrently at a convenience sample of shelters using a standardized questionnaire. Results: Overall, 2875 individuals at 24 shelters and 9 unsheltered outreach events underwent SARS-CoV-2 testing, and 2860 (99.5%) had conclusive test results. The SARS-CoV-2 prevalences were 2.1% (36/1684) among PEH living sheltered, 0.5% (3/628) among PEH living unsheltered, and 1.3% (7/548) among staff. Reporting fever, cough, or shortness of breath in the last week during symptom screening was 14% sensitive and 89% specific for identifying COVID-19 cases, compared with RT-PCR. Prevalences by shelter ranged 0–27.6%. Repeat testing 3–4 weeks later at 4 shelters documented decreased SARS-CoV-2 prevalences (0–3.9%). Of 24 shelters, 9 completed shelter assessments and implemented IPC measures as part of the COVID-19 response. Conclusions: PEH living in shelters experienced a higher SARS-CoV-2 prevalence compared with PEH living unsheltered. Facility-wide testing in congregate settings allowed for the identification and isolation of COVID-19 cases, and is an important strategy to interrupt SARS-CoV-2 transmission.This publication has 20 references indexed in Scilit:
- Symptom Screening at Illness Onset of Health Care Personnel With SARS-CoV-2 Infection in King County, WashingtonJAMA, 2020
- Assessment of SARS-CoV-2 Infection Prevalence in Homeless Shelters — Four U.S. Cities, March 27–April 15, 2020Morbidity and Mortality Weekly Report (MMWR), 2020
- Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19eLife, 2020
- Chronic Disease Burden of the Homeless: A Descriptive Study of Student-Run Free Clinics in Tampa, FloridaJournal of Community Health, 2018
- Cardiovascular Disease and HomelessnessJournal of the American College of Cardiology, 2018
- Morbidity and mortality in homeless individuals, prisoners, sex workers, and individuals with substance use disorders in high-income countries: a systematic review and meta-analysisThe Lancet, 2017
- Outbreak of Drug-Resistant Mycobacterium tuberculosis Among Homeless People in Atlanta, Georgia, 2008-2015Public Health Reports, 2017
- Homelessness, Unsheltered Status, and Risk Factors for MortalityPublic Health Reports, 2016
- Barriers to Homeless Persons Acquiring Health Insurance Through the Affordable Care ActThe Journal of Emergency Medicine, 2015
- Out-of-Hospital and Emergency Department Utilization by Adult Homeless PatientsAnnals of Emergency Medicine, 2007